title: [Bridging anticoagulation in patients with atrial fibrillation: Is it mandatory ?]
authors.affiliation: Unité de rythmologie, hopital Pitié-Salpétrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: francoise.hidden-lucet@aphp.fr.
authors.forename: F
authors.initials: F
authors.lastname: Hidden-Lucet
mesh_terms: D015110:4-Hydroxycoumarins / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000453:epidemiology; D003131:Combined Modality Therapy; D006801:Humans; D007192:Indenes / Q000627:therapeutic use; D007432:Intraoperative Period; D064887:Observational Studies as Topic; D019106:Postoperative Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D012307:Risk Factors; D013514:Surgical Procedures, Operative / Q000009:adverse effects / Q000379:methods; D054556:Venous Thromboembolism / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000627:therapeutic use
chemical_list: D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D007192:Indenes; C011664:antivitamins K; D014812:Vitamin K
keywords: Anticoagulation; Atrial fibrillation; Fibrillation atriale; Hazard; Risque